Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,431 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,448 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00599131 | Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) | terminated | Phase 2 | 4 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT00006994 | S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat | terminated | Phase 3 | 23 | SWOG Cancer Research NetworkNETWORK | 2 | Nov 18, 2015 |
| clinicaltrials |
| NCT00720083 | Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer | terminated | Phase 2 | 34 | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 17, 2015 | clinicaltrials |
| NCT02042885 | A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer | terminated | Phase 1 / Phase 2 | 79 | Otsuka Novel Products GmbHINDUSTRY | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00002735 | SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue | terminated | Phase 2 | 68 | SWOG Cancer Research NetworkNETWORK | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01949740 | Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal Cancer | terminated | — | 37 | University of ChicagoOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT01111942 | A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer | terminated | Early Phase 1 | 4 | Southern Illinois UniversityOTHER | 1 | Aug 5, 2015 | clinicaltrials |
| NCT02058017 | OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy | terminated | Phase 1 | 9 | National University Hospital, SingaporeOTHER | 1 | Jun 19, 2015 | clinicaltrials |
| NCT01694576 | NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation | terminated | Phase 2 | 10 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Jun 15, 2015 | clinicaltrials |
| NCT00176241 | Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer | terminated | Phase 1 | 7 | Susanne ArnoldOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01701466 | Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis | terminated | Phase 2 | 14 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT00088907 | Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer | terminated | Phase 3 | 270 | National Cancer Institute (NCI)NIH | 1 | May 6, 2015 | clinicaltrials |
| NCT00200408 | Assessment of Early Genetic Changes in Smokers | terminated | — | 10 | Montefiore Medical CenterOTHER | 1 | Apr 8, 2015 | clinicaltrials |
| NCT01548846 | Impact of Tomotherapy on Xerostomia and Quality of Life of Patients With Cancer of the Upper Aero-digestive Tract(TOQUAL) | terminated | Phase 2 | 11 | Centre Francois BaclesseOTHER | 1 | Mar 13, 2015 | clinicaltrials |
| NCT00934739 | A Study of High-Risk Oral Cavity Cancer | terminated | Phase 2 / Phase 3 | 150 | National Health Research Institutes, TaiwanOTHER | 0 | Feb 25, 2015 | clinicaltrials |
| NCT01219673 | Symptom Burden in Head and Neck Cancer | terminated | Phase 1 / Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 10, 2015 | clinicaltrials |
| NCT00525135 | Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer | terminated | Phase 2 | 5 | University of California, San FranciscoOTHER | 1 | Feb 3, 2015 | clinicaltrials |
| NCT00354523 | Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma | terminated | Phase 1 / Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 17, 2014 | clinicaltrials |
| NCT01587820 | Intra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx Cancer | terminated | Early Phase 1 | 1 | Southern Illinois UniversityOTHER | 1 | Dec 5, 2014 | clinicaltrials |
| NCT01254734 | Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer | terminated | N/A | 7 | City of Hope Medical CenterOTHER | 1 | Nov 10, 2014 | clinicaltrials |
| NCT01549379 | Dynamic Contrast Enhanced Computed Tomography (CT) for Head and Neck Cancer | terminated | N/A | 1 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Oct 15, 2014 | clinicaltrials |
| NCT01305772 | Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN(TOP0901) | terminated | Phase 2 | 6 | Neal ReadyOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT01682031 | Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy | terminated | Phase 2 | 18 | Roswell Park Cancer InstituteOTHER | 2 | Aug 22, 2014 | clinicaltrials |
| NCT01403259 | SOX as Salvage Treatment in Nasopharyngeal Carcinoma | terminated | Phase 2 | 16 | Fudan UniversityOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT00911326 | Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma | terminated | Phase 3 | 101 | Navidea BiopharmaceuticalsINDUSTRY | 1 | Aug 8, 2014 | clinicaltrials |
| NCT00530088 | Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or Throat | terminated | N/A | 30 | Roswell Park Cancer InstituteOTHER | 1 | Jul 4, 2014 | clinicaltrials |
| NCT00002947 | Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer | terminated | Phase 1 | 35 | Yale UniversityOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT01360827 | EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 1 | 13 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00507429 | Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer(FACT) | terminated | Phase 2 / Phase 3 | 80 | Mateon TherapeuticsINDUSTRY | 12 | Jun 9, 2014 | clinicaltrials |
| NCT00184028 | Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 2 | 12 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00115739 | Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma | terminated | Phase 2 | 11 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT00004227 | Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx | terminated | Phase 3 | 32 | University of Alabama at BirminghamOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT00095693 | Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer | terminated | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2014 | clinicaltrials |
| NCT01370876 | Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer | terminated | Phase 2 | 46 | Nang Kuang Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00574860 | EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer | terminated | Phase 3 | 240 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00113399 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery | terminated | Phase 3 | 15 | Radiation Therapy Oncology GroupNETWORK | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00906360 | Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT01412749 | TEST: Registry for Endoscopic Head and Neck Surgery(TEST) | terminated | — | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 28, 2013 | clinicaltrials |
| NCT00908024 | Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors | terminated | Phase 1 / Phase 2 | 54 | Bristol-Myers SquibbINDUSTRY | 2 | Jun 18, 2013 | clinicaltrials |
| NCT00062387 | Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | terminated | Phase 2 | 46 | National Cancer Institute (NCI)NIH | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00608751 | A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy(IMRT) | terminated | Early Phase 1 | 5 | Washington University School of MedicineOTHER | 1 | May 24, 2013 | clinicaltrials |
| NCT00898430 | Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy | terminated | — | 49 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 2, 2013 | clinicaltrials |
| NCT00898742 | Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer | terminated | — | 58 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 2, 2013 | clinicaltrials |
| NCT00126607 | Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer | terminated | Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT01058408 | RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer | terminated | Phase 1 | 3 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00033449 | Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00081211 | Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT01015664 | Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 1 / Phase 2 | 11 | University of Tennessee Cancer InstituteOTHER | 1 | Dec 17, 2012 | clinicaltrials |
| NCT00527982 | Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT01415986 | Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers | terminated | Phase 2 | 1 | University of ArkansasOTHER | 1 | Dec 3, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Dec 3, 2015source: clinicaltrials